Cited by 206

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation

Talora, Claudio, Sgroi, Dennis C., Crum, Christopher P., Dotto, G. Paolo·2002·Genes & Development

Abstract

The Notch family of cell surface receptors plays a key role in cell-fate determination and differentiation, functioning in a cell- and context-specific manner. In mammalian cells, Notch activation is generally thought to maintain stem cell potential and inhibit differentiation, thereby promoting carcinogenesis. However, in other contexts such as primary epithelial cells (keratinocytes), increased Notch activity causes exit from the cell cycle and/or commitment to differentiation. We now report that expression of the endogenous Notch1 gene is markedly reduced in a panel of cervical carcinoma cells whereas expression of Notch2 remains elevated, and Notch1 expression is similarly reduced or absent in invasive cervical cancers. Conversely, expression of activated Notch1 causes strong growth inhibition of HPV-positive, but not HPV-negative, cervical carcinoma cells, but exerts no such effects on other epithelial tumor cells. Increased Notch1 signaling, but not Notch2, causes a dramatic down-modulation of HPV-driven transcription of the E6/E7 viral genes, through suppression of AP-1 activity by up-regulation of the Fra-1 family member and decreased c-Fos expression. Thus, Notch1 exerts specific protective effects against HPV-induced transformation through suppression of E6/E7 expression, and down-modulation of Notch1 expression is likely to play an important role in late stages of HPV-induced carcinogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/gad.988902

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. Angel, 1991, The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation., Biochim. Biophys. Acta, 1072, 129
  2. 10.1126/science.284.5415.770 · DOI · Paper page
  3. Capobianco, 1997, Neoplastic transformation by truncated alleles of human NOTCH1/TAN1 and NOTCH2., Mol. Cell. Biol., 17, 6265, 10.1128/MCB.17.11.6265 · DOI
  4. Cohen, 1988, fra-1: A serum-inducible, cellular immediate-early gene that encodes a fos-related antigen., Mol. Cell. Biol., 8, 2063
  5. Daniel, 1997, The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions., J. Gen. Virol., 78, 1095, 10.1099/0022-1317-78-5-1095 · DOI
  6. Dyson, 1992, Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interaction with the same set of cellular proteins., J. Virol., 66, 6893, 10.1128/jvi.66.12.6893-6902.1992 · DOI · Paper page
  7. 10.1016/0092-8674(91)90111-B · DOI
  8. 10.1126/science.274.5289.998 · DOI
  9. 10.1101/gad.11.16.2090 · DOI · Paper page
  10. 10.1073/pnas.97.23.12513 · DOI · Paper page
  11. Goodwin, 1998, Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines., J. Virol., 72, 3925, 10.1128/JVI.72.5.3925-3934.1998 · DOI
  12. 10.1073/pnas.97.20.10978 · DOI · Paper page
  13. 10.1016/S0002-9440(10)65325-4 · DOI
  14. Jang, 2000, Notch signaling as a target in multimodality cancer therapy., Curr. Opin. Mol. Ther., 2, 55
  15. 10.1038/377355a0 · DOI
  16. Jesudasan, 1995, Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines., Am. J. Hum. Genet., 56, 705
  17. 10.1101/gad.11.16.2101 · DOI · Paper page
  18. Kato, 1997, Involvement of RBP-J in biological functions of mouse Notch1 and its derivatives., Development, 124, 4133, 10.1242/dev.124.20.4133 · DOI
  19. 10.1038/380079a0 · DOI · Paper page
  20. 10.1093/nar/26.23.5448 · DOI
  21. 10.1016/S0960-9822(00)00451-6 · DOI
  22. McMurray, 2001, Biology of human papillomaviruses., Intl. J. Exp. Pathol., 82, 15, 10.1046/j.1365-2613.2001.00177.x · DOI
  23. 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6 · DOI
  24. 10.1016/S0092-8674(00)80860-0 · DOI
  25. 10.1006/dbio.2000.9960 · DOI
  26. Naeger, 1999, Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein., Cell Growth Differ., 10, 413
  27. 10.1006/viro.2001.0867 · DOI
  28. 10.1093/emboj/20.13.3427 · DOI
  29. 10.1016/0092-8674(90)90409-8 · DOI · Paper page
  30. Scheffner, 1994, Functions of human papillomavirus proteins., Curr. Top. Microbiol. Immunol., 186, 83
  31. 10.1093/emboj/19.11.2558 · DOI
  32. Sgroi, 1999, In vivo gene expression profile analysis of human breast cancer progression., Cancer Res., 59, 5656
  33. Shou, 2001, Dynamics of notch expression during murine prostate development and tumorigenesis., Cancer Res., 61, 7291
  34. 10.1038/sj.onc.1202765 · DOI
  35. 10.1002/ijc.2910430422 · DOI
  36. Thierry, 1992, Two AP1 sites binding JunB are essential for human papillomavirus type 18 transcription in keratinocytes., J. Virol., 66, 3740, 10.1128/jvi.66.6.3740-3748.1992 · DOI
  37. Uyttendaele, 1996, Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene., Development, 122, 2251, 10.1242/dev.122.7.2251 · DOI
  38. 10.1093/emboj/19.21.5762 · DOI
  39. Welter, 1995, Differential expression of the fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation., Oncogene, 11, 2681
  40. 10.1074/jbc.270.21.12614 · DOI
  41. 10.1073/pnas.92.11.4972 · DOI
  42. 10.1073/pnas.92.14.6414 · DOI
  43. 10.1093/jnci/92.9.690 · DOI

Cited by

See all 206

Metadata

Authors
Talora, C., Sgroi, D. C., Crum, C. P., & Dotto, G. P.
Venue
Genes & Development
Published
2002-09-01
Volume
16
Issue
17
Pages
2252-2263
ISSN
  • 0890-9369
  • 1549-5477
Cited by
206
References
1
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review